We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Renal Cell Carcinoma

Journal Scan / Research · July 18, 2022

Effects of Statin Use on Nivolumab Efficacy in Patients With Advanced Renal Cell Carcinoma

European Journal of Cancer


Additional Info

Disclosure statements are available on the authors' profiles:

European Journal of Cancer
Statin use improves the efficacy of nivolumab in patients with advanced renal cell carcinoma
Eur. J. Cancer 2022 Jun 30;172(2022)191-198, M Santoni, F Massari, MR Matrana, U Basso, U De Giorgi, G Aurilio, S Buti, L Incorvaia, M Rizzo, A Martignetti, D Maslov, K Tawagi, E Philon, Z Blake, C Porta, N Battelli

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading